Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)

James D. Cox; JoAnn Stetz; Thomas F. Pajak

doi:10.1016/0360-3016(95)00060-c

Keywords

MedicineOncologyRadiation oncologyRadiation therapyMedical physicsCancerInternal medicineToxicity

Affiliated Institutions

Related Publications

Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study

Dionisio González , Johan Menten , D. Andries Bosch +4 more

The EORTC Radiotherapy Cooperative Group performed a prospective phase II study in glioblastoma multiforme using accelerated radiotherapy in escalating doses. The aims of the st...

1994 Radiotherapy and Oncology 51 citations

Health-related quality of life in patients with glioblastoma: a randomised controlled trial

Martin Klein , Roger Stupp , Corneel Coens +9 more

A randomised controlled trial of radiotherapy alone versus radiotherapy with concomitant and adjuvant temozolomide for patients with glioblastoma showed that survival was higher...

2005 The Lancet Oncology 323 citations

Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review

Fatma Ataman , Philip Poortmans , Roger Stupp +2 more

The phase III randomised European Organisation for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clinical Trail Group (NCIC) Intergroup trial ...

2004 European Journal of Cancer 36 citations

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

Thierry Gorlia , Martin J. van den Bent , Monika E. Hegi +9 more

A randomised trial published by the European Organisation for Research and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) Clinical Trials Group (...

2007 The Lancet Oncology 539 citations

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp , Monika E. Hegi , Warren Mason +21 more

In 2004, a randomised phase III trial by the European Organisation for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clinical Trials Group (NC...

2009 The Lancet Oncology 7605 citations

Publication Info

Year: 1995
Type: editorial
Volume: 31
Issue: 5
Pages: 1341-1346
Citations: 4740
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

4740

OpenAlex

Cite This

APA Style

                            
                                    James D. Cox, 
                                
                                    JoAnn Stetz, 
                                
                                    Thomas F. Pajak
                                
                            (1995). 
                            Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). 
                            International Journal of Radiation Oncology*Biology*Physics
                            , 31
                            (5)
                            , 1341-1346.
                            https://doi.org/10.1016/0360-3016(95)00060-c

Identifiers

DOI: 10.1016/0360-3016(95)00060-c